Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Beuselinck

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Acta Oncologica (Stockholm, Sweden)|August 27, 2021
Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implicationsEduard Roussel, Lisa Kinget, Annelies Verbiest, et al.
Clinical Genitourinary Cancer|August 18, 2024
Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 PolymorphismSajedeh Mobaraki, Peter Henrik Nissen, Frede Donskov, et al.
Oncoimmunology|November 21, 2015
Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)Etienne Becht, Nicolas A Giraldo, Benoit Beuselinck, et al.
Acta Oncologica (Stockholm, Sweden)|April 17, 2020
Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitorsBenoit Beuselinck, Steven Pans, Jurgen Bielen, et al.
Acta Oncologica (Stockholm, Sweden)|October 29, 2021
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort studySofie Demasure, Isabel Spriet, Philip R Debruyne, et al.
The Journal of Urology|December 5, 2012
A possible role for microRNA-141 down-regulation in sunitinib resistant metastatic clear cell renal cell carcinoma through induction of epithelial-to-mesenchymal transition and hypoxia resistanceJoost Berkers, Olivier Govaere, Pascal Wolter, et al.
Cancers|July 2, 2021
MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell CarcinomaLisa Kinget, Eduard Roussel, Annelies Verbiest, et al.
Acta Clinica Belgica|May 25, 2018
ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinibEmilie Werbrouck, Julie Bastin, Diether Lambrechts, et al.
Clinical Genitourinary Cancer|May 14, 2014
Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional studyAristotle Bamias, Kimon Tzannis, Athanasios Papatsoris, et al.
Clinical Genitourinary Cancer|March 6, 2018
Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase InhibitorsAnnelies Verbiest, Diether Lambrechts, Thomas Van Brussel, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Acta Oncologica (Stockholm, Sweden)|August 27, 2021
Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implicationsEduard Roussel, Lisa Kinget, Annelies Verbiest, et al.
Clinical Genitourinary Cancer|August 18, 2024
Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 PolymorphismSajedeh Mobaraki, Peter Henrik Nissen, Frede Donskov, et al.
Oncoimmunology|November 21, 2015
Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)Etienne Becht, Nicolas A Giraldo, Benoit Beuselinck, et al.
Acta Oncologica (Stockholm, Sweden)|April 17, 2020
Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitorsBenoit Beuselinck, Steven Pans, Jurgen Bielen, et al.
Acta Oncologica (Stockholm, Sweden)|October 29, 2021
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort studySofie Demasure, Isabel Spriet, Philip R Debruyne, et al.
The Journal of Urology|December 5, 2012
A possible role for microRNA-141 down-regulation in sunitinib resistant metastatic clear cell renal cell carcinoma through induction of epithelial-to-mesenchymal transition and hypoxia resistanceJoost Berkers, Olivier Govaere, Pascal Wolter, et al.
Cancers|July 2, 2021
MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell CarcinomaLisa Kinget, Eduard Roussel, Annelies Verbiest, et al.
Acta Clinica Belgica|May 25, 2018
ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinibEmilie Werbrouck, Julie Bastin, Diether Lambrechts, et al.
Clinical Genitourinary Cancer|May 14, 2014
Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional studyAristotle Bamias, Kimon Tzannis, Athanasios Papatsoris, et al.
Clinical Genitourinary Cancer|March 6, 2018
Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase InhibitorsAnnelies Verbiest, Diether Lambrechts, Thomas Van Brussel, et al.
Pageof 12